Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
24.00
-0.39 (-1.60%)
At close: Oct 8, 2025, 4:00 PM EDT
24.00
0.00 (0.00%)
After-hours: Oct 8, 2025, 4:00 PM EDT
KMTS Stock Forecast
Stock Price Forecast
The 5 analysts that cover KMTS stock have a consensus rating of "Buy" and an average price target of $26.8, which forecasts a 11.67% increase in the stock price over the next year. The lowest target is $23 and the highest is $29.
Price Target: $26.8 (+11.67%)
Analyst Consensus: Buy
* Price targets were last updated on Jul 17, 2025.
Analyst Ratings
The average analyst rating for KMTS stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $28 → $27 | Buy | Maintains | $28 → $27 | +12.50% | Jul 17, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $24 → $23 | Hold | Maintains | $24 → $23 | -4.17% | Apr 16, 2025 |
| Wolfe Research | Wolfe Research | Buy Initiates $29 | Buy | Initiates | $29 | +20.83% | Mar 31, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $28 | Buy | Initiates | $28 | +16.67% | Mar 31, 2025 |
| Stifel | Stifel | Strong Buy Initiates $28 | Strong Buy | Initiates | $28 | +16.67% | Mar 31, 2025 |
Financial Forecast
Revenue This Year
88.78M
from 59.82M
Increased by 48.42%
Revenue Next Year
132.53M
from 88.78M
Increased by 49.28%
EPS This Year
-2.38
from -5.13
EPS Next Year
-1.85
from -2.38
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 92.5M | 138.1M | |
| Avg | 88.8M | 132.5M | |
| Low | 83.4M | 124.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 54.7% | 55.5% | |
| Avg | 48.4% | 49.3% | |
| Low | 39.4% | 40.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.95 | -1.46 | |
| Avg | -2.38 | -1.85 | |
| Low | -2.57 | -2.28 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.